Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
March 17 2022 - 8:01AM
Edgar (US Regulatory)
Filed by Marrone Bio Innovations,
Inc.
(Commission File No. 001-36030)
Pursuant to Rule 425 under
the Securities Act of 1933, as amended
and deemed filed under Rule
14a-12 under the
Securities Exchange Act of
1934, as amended
Subject Company: Marrone Bio
Innovations, Inc. (Commission File No.: 001-36030)
Date: March 17, 2022
[The following presentation was posted on Marrone Bio Innovations,
Inc.’s website on March 17, 2022.]
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Jun 2024 to Jul 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Jul 2023 to Jul 2024